A Comparative Study of Temporalis Fascia Graft and Periosteal Graft in Myringoplasty

NCT ID: NCT06691139

Last Updated: 2024-11-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2024-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Comparative Study of Temporalis Fascia Graft and Periosteal Graft in Myringoplasty

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this clinical trials is to asses and compare the surgical outcomes of Temporalis fascia graft and periosteal graft in myringoplasty in terms of graft intake and audiological improvement

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myringoplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group (A) patients with periosteal graft

patients whose underwent to myringoplasty using periosteal graft

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia graft in patients ages from 12 years to 40 years

Intervention Type PROCEDURE

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft

Intervention Type OTHER

Group (A) Myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Myringoplasty operation using periosteal graft and myringoplasty using Temporalis fascia graft

Intervention Type PROCEDURE

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft in age from 12years to 40 years

Group (A) myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Intervention Type PROCEDURE

Myringoplasty operation using Temporalis fascia graft and Myringoplasty using periosteal graft in patients from 12 years to 40 years

(B) patients with Temporalis fascia graft

patients whose underwent to myringoplasty using Temporalis fascia graft

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia graft in patients ages from 12 years to 40 years

Intervention Type PROCEDURE

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft

Intervention Type OTHER

Group (A) Myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Myringoplasty operation using periosteal graft and myringoplasty using Temporalis fascia graft

Intervention Type PROCEDURE

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft in age from 12years to 40 years

Group (A) myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Intervention Type PROCEDURE

Myringoplasty operation using Temporalis fascia graft and Myringoplasty using periosteal graft in patients from 12 years to 40 years

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia graft in patients ages from 12 years to 40 years

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia

Intervention Type PROCEDURE

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft

Group (A) Myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Intervention Type OTHER

Myringoplasty operation using periosteal graft and myringoplasty using Temporalis fascia graft

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft in age from 12years to 40 years

Intervention Type PROCEDURE

Group (A) myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Myringoplasty operation using Temporalis fascia graft and Myringoplasty using periosteal graft in patients from 12 years to 40 years

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

age 12years to 40 years Small to moderate sized perforation . Dry tubotympanic chronic suppurative otitis media For more than 6 weeks .

Exclusion Criteria

Active discharge or superimposed otomycosis . Patients with sensorineural hearing loss. Patients with considerable nasal pathology.
Minimum Eligible Age

12 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mohamed Soltan Nada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Soltan Nada

Resident, otorhinolaryngology Head and neck department sohag university

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ahmed Nada

Role: PRINCIPAL_INVESTIGATOR

Sohag University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag university hospital

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-med-15-10-11MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.